Treating dyslipidaemia in primary care - The gap between policy and reality is large in the UK

被引：17

作者：

Monkman, D

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2000年 / 321卷 / 7272期

基金：

英国惠康基金;

关键词：

D O I：

10.1136/bmj.321.7272.1299

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1299 / 1300

页数：2

共 12 条

[1]

[Anonymous], 1997, Eur Heart J, V18, P1569

[2] Persistence of use of lipid-lowering medications - A cross-national study [J].

Avorn, J ;

Monette, J ;

Lacour, A ;

Bohn, RL ;

Monane, M ;

Mogun, H ;

LeLorier, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1458-1462

[3] A British cardiac society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events) - Principal results [J].

Bowker, TJ ;

Clayton, TC ;

Ingham, J ;

McLennan, NR ;

Hobson, HL ;

Pyke, SDM ;

Schofield, B ;

Wood, DA .

HEART, 1996, 75 (04) :334-342

[4] Secondary prevention in coronary heart disease: baseline survey of provision in general practice [J].

Campbell, NC ;

Thain, J ;

Deans, HG ;

Ritchie, LD ;

Rawles, JM .

BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7142) :1430-1434

[5] INVERSE CARE LAW [J].

HART, JT .

LANCET, 1971, 1 (7696) :405-+

[6]

*NAT HLTH SERV, 2000, NAT SERV FRAM COR HE

[7]

Neil H, 1999, INT J CLIN PRACT, V53, P422

[8] MIGHT TREATMENT OF HYPERCHOLESTEROLEMIA INCREASE NONCARDIAC MORTALITY [J].

OLIVER, MF .

LANCET, 1991, 337 (8756) :1529-1531

[9]

PEDERSEN TR, 1994, LANCET, V344, P1383

[10] Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey [J].

Primatesta, P ;

Poulter, NR .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7272) :1322-1325

← 1 2 →